Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
293,061,432
-
Total 13F shares
-
68,103,635
-
Share change
-
+64,310,105
-
Total reported value
-
$2,740,470,000
-
Price per share
-
$40.24
-
Number of holders
-
58
-
Value change
-
+$2,587,818,000
-
Number of buys
-
56
Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) as of Q4 2020
As of 31 Dec 2020,
AbCellera Biologics Inc. - Ordinary Shares (ABCL) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,103,635 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, SB Management Ltd, HARVARD MANAGEMENT CO INC, Falcon Edge Capital, LP, Founders Fund VII Management, LLC, Capital World Investors, Capital International Investors, and Duquesne Family Office LLC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.